Intec Pharma Ltd. (NTEC) financial statements (2020 and earlier)

Company profile

Business Address 12 HARTOM STREET
JERUSALEM, 777512
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1041
Cash and cash equivalents939
Short-term investments11
Receivables43
Total current assets:1444
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment312
Other noncurrent assets45
Other undisclosed noncurrent assets 0
Total noncurrent assets:818
TOTAL ASSETS:2162
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:55
Accounts payable00
Accrued liabilities33
Employee-related liabilities11
Other undisclosed accounts payable and accrued liabilities1 
Other undisclosed current liabilities43
Total current liabilities:88
Noncurrent Liabilities
Long-term debt and lease obligation1 
Operating lease, liability1
Liabilities, other than long-term debt10
Other liabilities10
Total noncurrent liabilities:10
Total liabilities:108
Stockholders' equity
Stockholders' equity attributable to parent1254
Common stock11
Additional paid in capital200195
Accumulated deficit(189)(142)
Total stockholders' equity:1254
TOTAL LIABILITIES AND EQUITY:2162

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Net investment income 1
Other income2 
Gross profit:21
Operating expenses(49)(43)
Other undisclosed operating loss (1)
Operating loss:(47)(43)
Loss from continuing operations before equity method investments, income taxes:(47)(43)
Other undisclosed income (loss) from continuing operations before income taxes0(0)
Loss from continuing operations before income taxes:(47)(43)
Income tax expense(1)(0)
Net loss available to common stockholders, diluted:(48)(44)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(48)(44)
Comprehensive loss, net of tax, attributable to parent:(48)(44)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: